Stay updated with breaking news from Richardb warren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This month’s rheumatology month in review showcases the efficacy of various medications for the treatment of psoriatic arthritis, underscores the importance of addressing workforce challenges, and explores non-pharmacological interventions. ....
Bimekizumab initiation resulted in greater or comparable efficacy regarding minimal disease activity and achievement of ACR50/70 compared with guselkumab. ....
/PRNewswire/ Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that post-hoc analysis data from the Phase 2b study of rocatinlimab (AMG 451/KHK4083), an. ....
Late-breaking presentation of data from the OSIRIS IIT PoC study of oral orismilast in hidradenitis suppurativa (HS) at the European Academy of Dermatology and. ....
Three-quarters of patients with generalized pustular psoriasis demonstrated response to treatment with an interleukin-36-targeted therapy as early as 4 weeks, according to a study.“Generalized pustular psoriasis (GPP) is a systemic inflammatory disease that can be severe, debilitating, and life-threatening,” Richard B. Warren, BSc, MBChB, MRCP, PhD, professor of dermatology and ....